CXCL8 and diabetic kidney disease: In vitro, podocyte CXCL8 release was strongly enhanced during a high-glucose challenge, suggesting that hyperglycemia may trigger podocyte CXCL8 production in diabetic patients, which could in turn activate death signals through an autocrine loop and facilitate diabetic nephropathy (133).